← Leaderboards
Brandon Krishna Lam
Johns Hopkins University
$127,744
Attributed
$127,744
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$127,744 · 1
By mechanism
F31$127,744 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Sekhar M Pothireddy$12,196,316
- Chien-Fu Hung$6,457,345
- Mark J Levis$4,468,842
- John Stephen Dumler$8,624,282
- Stephany Yi Tzeng$2,595,827
Others in their field
Other Emerging Leaders on “Adaptive Immunity”
- Yunda Huang · Fred Hutchinson Cancer Center$60,648,445
- Scott Hensley · University Of Pennsylvania$49,663,739
- S. Mark Tompkins · University Of Georgia$21,225,203
- Walter Orenstein · Emory University$16,408,221
- Gary Fanger · Rise Therapeutics, Llc$15,943,988
- Andrew Pekosz · Johns Hopkins University$14,871,138
Research focus
Adaptive ImmunityAdjuvantAlbuminsAnimalsAntigen PresentationAntigensAntigen-Specific T CellsAnti-Tumor Immune ResponseAntitumor ResponseBindingBiologicalB-LymphocytesBone MarrowBzip DomainCancer BurdenCancer ModelCancer TherapyCancer TypeCd4 Positive T LymphocytesCd8-Positive T-LymphocytesCellsChemokineChemotherapyActivating Transcription Factor
Grant awards (3)
The role of Albumin-Flt3L-induced cross-presenting dendritic cell expansion in antitumor immunity$37,208
F31 · FY2021 · CA · contact PI
The role of Albumin-Flt3L-induced cross-presenting dendritic cell expansion in antitumor immunity$45,520
F31 · FY2020 · CA · contact PI
The role of Albumin-Flt3L-induced cross-presenting dendritic cell expansion in antitumor immunity$45,016
F31 · FY2019 · CA · contact PI